v3 Template
O

OrbiMed

Healthcare ~440 employees
Founded
--
Employees (Est.)
~440
22 leaders known
Total Funding
$1.9B
Funding Rounds
1
Last Funding
2025-08-04

About OrbiMed

OrbiMed is a global investment firm focused on the healthcare industry, aiming to drive innovation, address unmet medical needs, and improve patient outcomes by investing in world-class healthcare companies. They provide tailored financing solutions and resources to build leading healthcare enterprises across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.

Products & Services

Investment in Biopharmaceuticals:Investing in companies developing drugs and therapies.
Investment in Medical Devices:Supporting innovations in medical equipment and technology.
Investment in Digital Health:Funding digital solutions for healthcare improvements.
Investment in Diagnostics:Backing diagnostic tools and technologies.
Investment in Healthcare Services:Investing in services that enhance healthcare delivery.
Portfolio Companies - Treeline Biosciences:Focused on targeted oncology drug discovery using mechanistic biology, medicinal chemistry, computational science, and structural biology.
Portfolio Companies - ADARx Pharmaceuticals:Developing an RNA targeting platform for inhibition, degradation, and editing, with novel delivery technologies.
Portfolio Companies - SpringWorks Therapeutics:Applying precision medicine to develop life-changing medicines for rare diseases and cancer.

Specialties

Biopharmaceuticals Medical Devices Digital Health Diagnostics Healthcare Services Oncology Drug Discovery RNA Targeting Platforms Precision Medicine

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Royalty and Credit Fund
T: -
FT: Royalty and Credit Fund 		A: 1860000000
MR: -
FA: $1.86 billion
FAN: 1860000000 		D: 2025-08-04
FD: 2025-08-04 		6 investors
Royalty and Credit Fund Latest
2025-08-04
$1.9B
6 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

S

Sven H. Borho, CFA

Managing Partner

C

Carl L. Gordon, Ph.D., CFA

Managing Partner

LinkedIn (Pro only)
W

W. Carter Neild, CFA

Managing Partner

LinkedIn (Pro only)
G

Geoffrey C. Hsu, CFA

General Partner

C

C. Scotland Stevens

General Partner

D

David Bonita, M.D.

General Partner

View 19 more team members with Pro

Unlock Full Team Directory

Recent News

OrbiMed Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Healthcare
Company Size
~440 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro